The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Ahead of the annual Antibiotics Awareness Day, VALUE-Dx* project team and EU stakeholders, patients and health professionals will come together to address challenges and discuss prospective of battling antimicrobial resistance. Project researchers will bring the spotlight on the role of novel cost-effective diagnostics of infections, introducing innovative solutions to combat antimicrobial resistance. Improving clinical care and achieving better patient outcomes is in the core of the approach.
The event will take place online, in the form of a live webinar, hosted by the European Respiratory Society, and moderated by Rene Wyndham.
The programme will feature the following speakers:
Patient testimony: AMR and antibiotic use in management and treatment of my chronic lung conditions – Fran Husson, Patient Advocate
AMR and respiratory infections: VALUE-Dx – A unique European Public-Private Partnership – Herman Goossens, University of Antwerp, VALUE-Dx project consortium
Effect of antimicrobial stewardship on resistance rates – Evelina Tacconelli, University of Verona, VALUE-Dx project consortium
Impact and value of diagnostics: clinical, public health and economic perspective – Maarten Postma, University of Groningen, VALUE-Dx project consortium
AMR and antimicrobial consumption in the EU/EEA – Dominique L. Monnet, ECDC
EU initiatives to tackle AMR – John F. Ryan, DG SANTE, European Commission
*About the project: VALUE-Dx is the first Innovative Medicines Initiative (IMI) project initiated by 6 in vitro diagnostic companies who joined forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes. Unique in its multidisciplinary consortium, it involves clinicians, microbiologists, health economists, social scientists, and industry, to help build the medical and economic case for rapid diagnostics as a public good in the fight against antibiotic resistance.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 820755. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and bioMérieux SA, Janssen Pharmaceutica NV, Accelerate Diagnostics S.L., Abbott, Bio-Rad Laboratories, BD Switzerland Sàrl, and The Wellcome Trust Limited.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.